Interactions of Methotrexate, Trimetrexate and Piritrexim with Human and L. casei Dihydrofolate Reductases — Steady State Inhibition Constants and Dissociation Rates

Autor: Nixon P. F., Waltham M. C.

Publikováno v: Pteridines, Vol 3, Iss 1-2, Pp 123-124 (1991)

Externí odkaz: https://doaj.org/article/757f6fbbe5c44f34aa05be04c85cce72

Methotrexate resistance in an in vivo mouse tumor due to a non-active-site dihydrofolate reductase mutation.

Autor: Dicker, A P, Waltham, M C, Volkenandt, M, Schweitzer, B I, Otter, G M, Schmid, F A, Sirotnak, F M, Bertino, J R

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America; December 1993, Vol. 90 Issue: 24 p11797-11801, 5p

Myoepithelial molecular markers in human breast carcinoma PMC42-LA cells are induced by extracellular matrix and stromal cells

Autor: Lebret, S. C., Newgreen, D. F., Waltham, M. C., Price, J. T., Erik Walter Thompson, Ackland, M. L.

Publikováno v: Scopus-Elsevier

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5081a815ba20b67847105f84aca91fac
http://www.scopus.com/inward/record.url?eid=2-s2.0-33846890403&partnerID=MN8TOARS

Dihydrofolate reductase protein inhibits its own translation by binding to dihydrofolate reductase mRNA sequences within the coding region.

Autor: Ercikan-Abali EA; Program of Molecular Pharmacology and Therapeutics, Cornell University Medical College, Memorial Sloan-Kettering Cancer Center, New York 10021, USA., Banerjee D, Waltham MC, Skacel N, Scotto KW, Bertino JR

Publikováno v: Biochemistry [Biochemistry] 1997 Oct 07; Vol. 36 (40), pp. 12317-22.

Active site-directed double mutants of dihydrofolate reductase.

Autor: Ercikan-Abali EA; Program of Molecular Pharmacology and Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA., Mineishi S, Tong Y, Nakahara S, Waltham MC, Banerjee D, Chen W, Sadelain M, Bertino JR

Publikováno v: Cancer research [Cancer Res] 1996 Sep 15; Vol. 56 (18), pp. 4142-5.